Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PMCB - PharmaCyte Biotech: Buy The 'Dump'

PMCB - PharmaCyte Biotech: Buy The 'Dump'

PharmaCyte Biotech Inc.
  • I recommend that you nibble a few shares of PharmaCyte Biotech if interested in a “trade” or a very high-risk long-term buy-and-hold.
  • Historically, the company (or its investors) has proved to be quite expert in self-promotion.
  • Your entry price per share should be at or below $4.25.
  • The direct offering is for 14 million shares plus up to 7 million shares, through warrants, for minimum proceeds of $70 million.
  • Gross proceeds from NASDAQ offering for $15 million plus the $70 million direct offering will be used for Phase 2b clinical trials.

For further details see:

PharmaCyte Biotech: Buy The 'Dump'
Stock Information
Company Name: PharmaCyte Biotech Inc.
Stock Symbol: PMCB
Market: OTC
Website: pharmacyte.com
Menu
PMCB PMCB Quote PMCB Short PMCB News PMCB Articles PMCB Message Board
Get PMCB Alerts

News, Short Squeeze, Breakout and More Instantly...